Ebp1 p48 promotes oncogenic activities in human colon cancer cells through regulation of TIF-90-mediated ribosomal RNA synthesis

Journal of Cellular Physiology
Dang Quan NguyenLe Xuan Truong Nguyen

Abstract

The ErbB3-binding protein 1 (Ebp1) has been reported as either an oncogenic regulator or a tumor suppressor in a variety of cancers. Here, we show that Ebp1 p48, a predominant expression isoform, is highly expressed in the majority of human colon tumor cells compared with normal adjacent tissues and its expression is required for the oncogenic activities of these cells. Depletion of Ebp1 expression in primary colon cancer cells inhibits cell proliferation, colony forming, and invasion in vitro as well as tumor formation in vivo and enhances cell sensitivity to irradiation. We further demonstrated that Ebp1 interacts with TIF-90, a splice variant of transcription initiation factor IA (TIF-IA) of the RNA polymerase I complex, allowing for regulation of ribosomal RNA (rRNA) synthesis and oncogenesis in human colon cancer cells. Moreover, Ebp1 expression is essential for Akt protected TIF-90 stability by preventing TIF-90's ubiquitination by Mdm2 and hence, its proteasomal degradation. The results of the present study support a mechanism of underlying oncogenic activities by means of Ebp1 through regulation of TIF-90-mediated rRNA synthesis and suggest the potential therapeutic treatment of colon cancer by targeting Ebp1 and its si...Continue Reading

References

Jul 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Zhixue LiuKeqiang Ye
Jul 21, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Saskia J A M SantegoetsTanja D de Gruijl
Aug 11, 2007·The EMBO Journal·Tom P MonieStephen Curry
Nov 28, 2008·Molecular Biology of the Cell·Zhixue LiuKeqiang Ye
Dec 20, 2008·BMC Cell Biology·Yuexing ZhangAnne W Hamburger
Dec 4, 2013·Proceedings of the National Academy of Sciences of the United States of America·Le Xuan Truong Nguyen, Beverly S Mitchell
May 23, 2014·Blood·Le Xuan Truong NguyenBeverly S Mitchell
Oct 23, 2014·Journal of Cellular Physiology·Le Xuan Truong NguyenBeverly S Mitchell
Feb 19, 2015·Blood·Le Xuan Truong NguyenBeverly S Mitchell
Jan 28, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Le Xuan Truong NguyenBeverly S Mitchell
Aug 5, 2018·Journal of Cellular Physiology·Dang Quan NguyenLe Xuan Truong Nguyen

❮ Previous
Next ❯

Citations

Oct 31, 2020·Cells·Sophie Nait SlimaneHichem C Mertani
Jan 23, 2021·RNA·Varun BhaskarJeffrey A Chao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.